NEW YORK (GenomeWeb News) – Tet Systems has acquired from The Academic Medical Center (AMC) and the Technology Foundation STW in the Netherlands the rights to use and commercialize gene expression-related Tet technologies covered by eight patent applications.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.